Your browser doesn't support javascript.
loading
Clinical characteristics, survival analysis and influencing factors of distant metastasis in patients with acromelanomas: A retrospective study.
Fang, Yan; Yongqian, Zhu; Yin, Lu; Li, Min; Mei, Zhang; Jing, Yang; Di, Wu.
Afiliação
  • Fang Y; Department of Dermatology, Nanjing Pukou People's Hospital, Nanjing, Jiangsu, People's Republic of China.
  • Yongqian Z; Department of Information, Jiangsu Provincial People's Hospital, Nanjing, Jiangsu, People's Republic of China.
  • Yin L; Department of Dermatology, Nanjing Pukou People's Hospital, Nanjing, Jiangsu, People's Republic of China.
  • Li M; Department of Ultrasound, Jiangdong Community Service Center, Nanjing, Jiangsu, People's Republic of China.
  • Mei Z; Department of Pathology, Nanjing Pukou People's Hospital, Nanjing, Jiangsu, People's Republic of China.
  • Jing Y; Department of Dermatology, Nanjing Pukou People's Hospital, Nanjing, Jiangsu, People's Republic of China.
  • Di W; Department of Dermatology, Jiangsu Provincial People's Hospital, Nanjing, Jiangsu, People's Republic of China.
Medicine (Baltimore) ; 103(23): e38230, 2024 Jun 07.
Article em En | MEDLINE | ID: mdl-38847674
ABSTRACT
The prognosis of acromelanomas (AM) is worse. The objective of this study was to investigate the clinical features of distant metastasis of AM and the factors affecting the survival and prognosis of patients. In this study, a retrospective study was conducted to select 154 AM patients admitted to Nanjing Pukou People's Hospital from January 2018 to April 2021 for clinical research. The clinical characteristics of distant metastasis were statistically analyzed, and the survival curve was drawn with 5-year follow-up outcomes. The median survival time of the patients was calculated, and the clinicopathological features and peripheral blood laboratory indexes of the surviving and dead patients were analyzed. Logistic regression model was used to analyze the risk factors affecting the prognosis of AM patients. In this study, 154 patients with AM were treated, including 88 males and 76 females, aged from 27 to 79 years old, with an average age of (59.3 ±â€…11.7) years old. Among them, 90 cases had distant metastasis. The main metastatic sites were lung (47.78%) and lymph nodes (42.22%). Among them, single site metastasis accounted for 41.11% and multiple site metastasis 58.89%. 89 cases survived and 65 cases died. The survival time was 22 months to 60 months, and the median survival time was 48.0 months. The Breslow thickness, stage at diagnosis, distant metastasis, site of metastasis and ulceration were compared between the survival group and the death group (P < .05). serum lactate dehydrogenase (LDH), neutrophil-to-lymphocyte ratio (NLR) and lymphocyte monocyte ratio (LMR) were compared between the survival group and the death group (P < .05). The results of Logistic regression model showed that LDH ≥ 281 U/L, NLR ≥ 2.96, LMR ≤ 3.57, newly diagnosed stage > stage II, distant metastasis, multiple site metastasis and tumor ulcer were independent risk factors for poor prognosis of AM patients (P < .05). Patients with AM had a higher proportion of distant metastasis, mainly lung and lymph node metastasis. Increased LDH, increased NLR, decreased LMR, higher initial stage, distant metastasis, multiple site metastasis, and combined tumor ulcer were closely related to the poor prognosis of patients after surgery.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article